. Total CTSS activities were reduced with CTSS-C25A mutant. 
Figure S2. CTSS inhibition delayed EGF-mediated EGFR degradation process in various cell lines
Human non-small cell lung carcinoma A549, PC9, and PC9-IR, human breast cancer cell line MDA-MB-231, human pancreatic carcinoma Panc1, and human colon adenocarcinoma HT29 cell lines with and without the treatment of 20 μM 6r were stimulated with 100 ng/mL EGF for 2 h. Cell lysates were separated through SDS-PAGE and then probed with EGFR antibodies.
